Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis (original) (raw)
Beal MF (2007) Mitochondria and neurodegeneration. Novartis Found Symp287: 183–192 CASPubMed Google Scholar
Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol7: 97–109 ArticleCASPubMed Google Scholar
Schapira AH et al. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem54: 823–827 ArticleCASPubMed Google Scholar
Parker WD Jr et al. (2008) Complex I deficiency in Parkinson's disease frontal cortex. Brain Res1189: 215–218 ArticleCASPubMed Google Scholar
Keeney PM et al. (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci26: 5256–5264 ArticleCASPubMedPubMed Central Google Scholar
Haas RH et al. (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol37: 714–722 ArticleCASPubMed Google Scholar
Penn AM et al. (1995) Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. Neurology45: 2097–2099 ArticleCASPubMed Google Scholar
Swerdlow RH et al. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol40: 663–671 ArticleCASPubMed Google Scholar
Gu M et al. (1998) Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol44: 177–186 ArticleCASPubMed Google Scholar
Hu MT et al. (2000) Cortical dysfunction in non-demented Parkinson's disease patients: a combined 31P-MRS and 18FDG-PET study. Brain123: 340–352 ArticlePubMed Google Scholar
Rango M et al. (2005) Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab26: 283–290 ArticleCAS Google Scholar
Bowen BC et al. (1995) Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiol16: 61–68 CASPubMedPubMed Central Google Scholar
Henchcliffe C et al.: Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial function in Parkinson's disease. Ann N Y Acad Sci, in press
Dexter DT et al. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem52: 381–389 ArticleCASPubMed Google Scholar
Zhang J et al. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol154: 1423–1429 ArticleCASPubMedPubMed Central Google Scholar
Perry TL et al. (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett67: 269–274 ArticleCASPubMed Google Scholar
Beal MF (1998) Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol44 (Suppl 1): S110–S114 ArticleCASPubMed Google Scholar
Langston JW et al. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science219: 979–980 ArticleCASPubMed Google Scholar
Betarbet R et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci3: 1301–1306 ArticleCASPubMed Google Scholar
Coulom H et al. (2004) Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci24: 10993–10998 ArticleCASPubMedPubMed Central Google Scholar
Cicchetti F et al. (2005) Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol Dis20: 360–371 ArticleCASPubMed Google Scholar
Greenamyre JT et al. (1994) Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann Neurol35: 655–661 ArticleCASPubMed Google Scholar
Swerdlow RH et al. (1998) Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol44: 873–881 ArticleCASPubMed Google Scholar
Simon DK et al. (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology53: 1787–1793 ArticleCASPubMed Google Scholar
Luoma P et al. (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet364: 875–882 ArticleCASPubMed Google Scholar
Bender A et al. (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet38: 515–517 ArticleCASPubMed Google Scholar
Srivastava S et al. (2005) Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum Mol Genet14: 893–902 ArticleCASPubMed Google Scholar
Pyle A et al. (2005) Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol57: 564–567 ArticlePubMed Google Scholar
Devi L et al. (2008) Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem283: 9089–9100 ArticleCASPubMedPubMed Central Google Scholar
Cole NB et al. (2008) Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res314: 2076–2089 ArticleCASPubMedPubMed Central Google Scholar
Shavali S et al. (2008) Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci Lett439: 125–128 ArticleCASPubMedPubMed Central Google Scholar
Martin LJ et al. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci26: 41–50 ArticleCASPubMedPubMed Central Google Scholar
Parihar MS et al. (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci65: 1272–1284 ArticleCASPubMed Google Scholar
Buttner S et al. (2008) Functional mitochondria are required for α-synuclein toxicity in aging yeast. J Biol Chem283: 7554–7560 ArticleCASPubMed Google Scholar
Song DD et al. (2004) Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP. Exp Neurol186: 158–172 ArticleCASPubMed Google Scholar
Kuroda Y et al. (2006) Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet15: 883–895 ArticleCASPubMed Google Scholar
Greene JC et al. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA100: 4078–4083 ArticleCASPubMedPubMed Central Google Scholar
Pesah Y et al. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development131: 2183–2194 ArticleCASPubMed Google Scholar
Palacino JJ et al. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem279: 18614–18622 ArticleCASPubMed Google Scholar
Muftuoglu M et al. (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord19: 544–548 ArticlePubMed Google Scholar
Silvestri L et al. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet14: 3477–3492 ArticleCASPubMed Google Scholar
Hoepken HH et al. (2007) Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis25: 401–411 ArticleCASPubMed Google Scholar
Clark IE et al. (2006) Drosophila Pink1 is required for mitochondrial function and interacts genetically with parkin. Nature441: 1162–1166 ArticleCASPubMed Google Scholar
Yang Y et al. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA105: 7070–7075 ArticlePubMedPubMed Central Google Scholar
Petit A et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem280: 34025–34032 ArticleCASPubMed Google Scholar
Wood-Kaczmar A et al. (2008) PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE3: e2455 ArticleCASPubMedPubMed Central Google Scholar
Exner N et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci27: 12413–12418 ArticleCASPubMedPubMed Central Google Scholar
Bonifati V et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science299: 256–259 ArticleCASPubMed Google Scholar
Yokota T et al. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun312: 1342–1348 ArticleCASPubMed Google Scholar
Zhang L et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet14: 2063–2073 ArticleCASPubMed Google Scholar
Canet-Aviles RM et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA101: 9103–9108 ArticleCASPubMedPubMed Central Google Scholar
Meulener M et al. (2005) Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol15: 1572–1577 ArticleCASPubMed Google Scholar
Park J et al. (2005) Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene361: 133–139 ArticleCASPubMed Google Scholar
Yang Y et al. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA102: 13670–13675 ArticleCASPubMedPubMed Central Google Scholar
Shendelman S et al. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation. PLoS Biol2: e362 ArticleCASPubMedPubMed Central Google Scholar
Meulener MC et al. (2005) DJ-1 is present in a large molecular complex in human brain tissue and interacts with α-synuclein. J Neurochem93: 1524–1532 ArticleCASPubMed Google Scholar
West AB et al. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA102: 16842–16847 ArticleCASPubMedPubMed Central Google Scholar
Martins LM et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol24: 9848–9862 ArticleCASPubMedPubMed Central Google Scholar
Strauss KM et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet14: 2099–2111 ArticleCASPubMed Google Scholar
Ravagnan L et al. (2002) Mitochondria, the killer organelles and their weapons. J Cell Physiol192: 131–137 ArticleCASPubMed Google Scholar
Plun-Favreau H et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol9: 1243–1252 ArticleCASPubMed Google Scholar
Simon-Sanchez J et al. (2008) Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum Mol Genet17: 1988–1993 ArticleCASPubMedPubMed Central Google Scholar
Beal MF (2004) Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr36: 381–386 ArticleCASPubMed Google Scholar
McCarthy S et al. (2004) Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble coenzyme Q10. Toxicol Appl Pharmacol201: 21–31 ArticleCASPubMed Google Scholar
Menke T et al. (2003) Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential. Biofactors18: 65–72 ArticleCASPubMed Google Scholar
Beal MF et al. (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res783: 109–114 ArticleCASPubMed Google Scholar
Horvath TL et al. (2003) Coenzyme Q induces nigral mitochondrial uncoupling and prevents nigral cell loss in a primate model of Parkinson's disease. Endocrinology144: 2757–2760 ArticleCASPubMed Google Scholar
Stamelou M et al. (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord23: 942–949 ArticlePubMed Google Scholar
Shults CW et al. (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol59: 1541–1550 ArticlePubMed Google Scholar
The NINDS NET-PD Investigators (2007) A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology68: 20–28
The NINDS NET-PD Investigators (2006) A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology66: 664–671
Klivenyi P et al. (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis21: 541–548 ArticleCASPubMed Google Scholar
Parkinson Study Group (2004) A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol61: 561–566
Lagouge M et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell127: 1109–1122 ArticleCASPubMed Google Scholar
Lu KT et al. (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem56: 6910–6913 ArticleCASPubMed Google Scholar
Ko L et al. (2000) Sensitization of neuronal cells to oxidative stress with mutated human α-synuclein. J Neurochem75: 2546–2554 ArticleCASPubMed Google Scholar
Ostrerova-Golts N et al. (2000) The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci20: 6048–6054 ArticleCASPubMedPubMed Central Google Scholar
Smith WW et al. (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA102: 18676–18681 ArticleCASPubMedPubMed Central Google Scholar
Darios F et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet12: 517–526 ArticleCASPubMed Google Scholar
Park J et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature441: 1157–1161 ArticleCASPubMed Google Scholar
Gandhi S et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain129: 1720–1731 ArticleCASPubMed Google Scholar
Choi J et al. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem281: 10816–10824 ArticleCASPubMed Google Scholar
Menzies FM et al. (2005) Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr Biol15: 1578–1582 ArticleCASPubMed Google Scholar